Procleix UltrioPlex E Assay

HIV, HBV and HCV nucleic acid · class IV · Until 19/02/2034

Registration no.
80134860306
Process no.
25351652144202219
Status
Until 19/02/2034
Device type
HIV, HBV and HCV nucleic acid (ÁCIDO NUCLÉICO DE VÍRUS HIV, HBV E HCV)
Risk class
IV
Registration holder
GRIFOLS BRASIL LTDA CNPJ 02.513.899/0001-71 · 342 registrations
Manufacturer
GRIFOLS DIAGNOSTICS SOLUTIONS INC · United States
Published
19/02/2024
Valid until
19/02/2034
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other hiv, hbv and hcv nucleic acid registrations (13 in total, see all)

ProductClass HolderPublishedStatus
Discriminatory Probe Reagent kit (Procleix UltrioPlex E)
80134860320
IV GRIFOLS BRASIL LTDA 15/09/2025 Until 15/09/2035
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay
80134860319
IV GRIFOLS BRASIL LTDA 28/07/2025 Until 28/07/2035
Procleix Ultrio Elite Assay Calibrators
80134860317
IV GRIFOLS BRASIL LTDA 07/07/2025 Until 07/07/2035
Família Procleix UltrioPlex E Assay Calibrators
80134860314
IV GRIFOLS BRASIL LTDA 23/06/2025 Until 23/06/2035
Kit NAT PLUS HIV/HBV/HCV/Malária Bio-Manguinhos
80142170056
IV FUNDACAO OSWALDO CRUZ 21/03/2022 Until 21/03/2032
Cobas HBV/HCV/HIV-1 Control Kit
10287411180
IV ROCHE DIAGNÓSTICA BRASIL LTDA 19/12/2016 Until 19/12/2036
COBAS MPX
10287411182
IV ROCHE DIAGNÓSTICA BRASIL LTDA 19/12/2016 Until 19/12/2026
Cobas HBV/HCV/HIV-1 Control Kit 4800
10287411161
IV ROCHE DIAGNÓSTICA BRASIL LTDA 05/09/2016 Until 05/09/2036